Last updated: 2026-09-16 10:31:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
AngioDynamics, Inc. (ANGO) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $15.71, with a market capitalisation of $641.07M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $9.39 to $16.29. This page covers its latest market performance, valuation, price trends and company information.
$641.07M | |
$15.69 | |
$32.00 | |
$5.26 | |
$15.68 | |
-- | |
459.08K | |
-- | |
$16.29 | |
$9.39 | |
-- | |
-- |
AngioDynamics, Inc. (ANGO) is trading at $15.71 in pre-market trading as of 2026-09-16 09:19:00, up 0.18% ($0.03) from the previous close of $15.68
Pre-market trading shows how investors are pricing ANGO before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.
Over the past seven days, AngioDynamics, Inc. (ANGO) moved from $15.20 to $15.71, representing a gain of 3.35% ($0.51).
The stock traded between $14.85 and $15.79 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 417.13 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 91.6%
ANGO is currently trading at $15.71, placing it 91.6% of the way from its 52-week low of $9.39 to its 52-week high of $16.29. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
AngioDynamics Inc is a dynamic, diversified medical technology company committed to expanding treatment options and improving patient outcomes and quality of life by designing, manufacturing, and selling products and technologies that aid clinicians in the treatment of patients with cardiovascular disease and cancer diagnoses. The company's execution plan is built on R&D, clinical and regulatory pathway expansion, and customer-centric sales performance. The company's product offerings fall within two segments, Med Tech and Med Device. Med Tech includes Auryon and Thrombectomy, while Med Device has Peripheral Products (Interventional Devices), Ports, and Microwave Ablation. Geographically operates in the USA and Other countries; maximum revenue from the USA.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 632 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of AngioDynamics, Inc. (ANGO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.